We are live on
!
Find out more
Medifast
MED
MED
264 hedge funds and large institutions have $1.03B invested in Medifast in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 91 increasing their positions, 95 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
2.26% more ownership
Funds ownership: 84.15% → 86.41% (+2.3%)
4% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 95
7% less funds holding
Funds holding: 284 → 264 (-20)
17% less call options, than puts
Call options by funds: $8.45M | Put options by funds: $10.1M
30% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 57
41% less capital invested
Capital invested by funds: $1.75B → $1.03B (-$716M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
264
Holders Change
-20
Holders Change %
-7.04%
% of All Funds
4.55%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
40
Increased
91
Reduced
95
Closed
57
Calls
$8.45M
Puts
$10.1M
Net Calls
-$1.69M
Net Calls Change
+$337K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$19M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$15M |
| 3 |
CCM
Chimera Capital Management
New York
|
+$12.7M |
| 4 |
Millennium Management
New York
|
+$8.29M |
| 5 |
JP Morgan Chase
New York
|
+$7.87M |
